Specialty Oncology Pharmacy in Brazil ANVISA Import Rules Receita Federal Clearance and Cold Chain to São Paulo
Author: Dra. Camila Ferreira
On September 22, 2026, Brazilian oncology pharmacy networks in São Paulo and Rio de Janeiro published updated sourcing protocols for importing high-value biological cancer medicines under ANVISA oversight. Given rising demand for immunotherapies and targeted kinase inhibitors, establishing a compliant import pathway through Receita Federal (RFB) customs is essential for treatment continuity.
At Critical Kare Pharma, we coordinate with Brazilian customs brokers to deliver authentic oncology medicines with full ANVISA documentation, COA verification, and validated cold-chain packaging to all 26 states and the Federal District.
ANVISA & Receita Federal Compliance Checklist
- Valid Brazilian Prescription (Receita): A prescription from a CRM-registered oncologist is mandatory for personal import clearance.
- ANVISA Personal Import Authorization: Shipments must include regulatory declarations supporting individual therapeutic use under ANVISA Resolution frameworks.
- Batch Verification: Every vial and carton is matched against manufacturer Certificate of Analysis (COA) before dispatch.
- 8–14 Day Delivery Window: Priority air freight with GDP thermal shippers reaches São Paulo, Brasília, and regional hubs within 8–14 business days.
See our full Brazil guide at Brazil cancer medicine page or email support@Critical Kare Pharma.com.
